| Theme | Abdominal Ultrasonography up-to-date | |
|---|---|---|
| Title | Ultrasound Guided Hepatic Tumor Biopsy and Treatment | |
| Publish Date | 2011/08 | |
| Author | Kazushi Numata | Gastroenterological Center, Yokohama City University Medical Center |
| Author | Hiroyuki Fukuda | Gastroenterological Center, Yokohama City University Medical Center |
| Author | Manabu Morimoto | Gastroenterological Center, Yokohama City University Medical Center |
| Author | Masaaki Kondo | Gastroenterological Center, Yokohama City University Medical Center |
| Author | Akito Nozaki | Gastroenterological Center, Yokohama City University Medical Center |
| Author | Katsuaki Tanaka | Gastroenterological Center, Yokohama City University Medical Center |
| [ Summary ] | Fusion imaging can fuse US images with multiplanar reconstructed computed tomography (CT) or magnetic resonance (MR) images on a single screen in real time using a LOGIQ E9(GE Healthcare, Milwaukee, WI). To provide histological diagnosis of hepatic lesions which do not exhibit arterial hypervascularization or venous washout on contrast-enhanced CT or contrast-enhanced US but are detected in the hepatobiliary phase of contrast-enhanced MR with gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA), the lesions must be detectable using US imaging. Imaging such as conventional US or contrast-enhanced US may be employed, so that a biopsy may be performed. We used fusion imaging combining, which fuses B-mode images with the hepatobiliary phase of contrast-enhanced MR images Gd-EOBDTPA as a reference image, for the detection of hepatic lesions. We also performed ablation therapy for hypervascular hepatocellular carcinoma lesions which exhibited arterial hypervascularization and venous washout on contrast-enhanced T or contrast-enhanced US. Those lesions were not detected by using B-mode guided fusion imaging combining arterial phase contrast-enhanced CT or MRI with early or late phase contrast-enhanced US. | |